nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—Masoprocol—IGF1R—adrenal gland cancer	0.852	1	CrCbGaD
Dobutamine—COMT—Dopamine metabolism—PRKACA—adrenal gland cancer	0.0196	0.133	CbGpPWpGaD
Dobutamine—ADRB2—Arf6 signaling events—TSHR—adrenal gland cancer	0.00639	0.0433	CbGpPWpGaD
Dobutamine—COMT—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00573	0.0389	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Other—GNRHR—adrenal gland cancer	0.00557	0.0377	CbGpPWpGaD
Dobutamine—ADRB2—Arf6 trafficking events—TSHR—adrenal gland cancer	0.00504	0.0342	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—KCNJ5—adrenal gland cancer	0.00439	0.0298	CbGpPWpGaD
Dobutamine—ADRB1—Endothelin Pathways—GNAS—adrenal gland cancer	0.00398	0.027	CbGpPWpGaD
Dobutamine—ADRB1—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.00384	0.026	CbGpPWpGaD
Dobutamine—ADRB2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.00375	0.0254	CbGpPWpGaD
Dobutamine—ADRB1—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.00237	0.0161	CbGpPWpGaD
Dobutamine—ADRB2—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.00232	0.0157	CbGpPWpGaD
Dobutamine—COMT—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0022	0.0149	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—SDHB—adrenal gland cancer	0.00218	0.0148	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00212	0.0144	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00207	0.014	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—SDHB—adrenal gland cancer	0.00204	0.0138	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—PRKACA—adrenal gland cancer	0.00168	0.0114	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00161	0.0109	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00158	0.0107	CbGpPWpGaD
Dobutamine—ADRB1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00147	0.00996	CbGpPWpGaD
Dobutamine—CA2—Metabolism—SDHB—adrenal gland cancer	0.00144	0.00978	CbGpPWpGaD
Dobutamine—ADRB2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00144	0.00974	CbGpPWpGaD
Dobutamine—ADRB2—Arf6 signaling events—EGFR—adrenal gland cancer	0.00141	0.00958	CbGpPWpGaD
Dobutamine—ADRB2—Arf6 trafficking events—CTNNB1—adrenal gland cancer	0.00141	0.00955	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—SDHD—adrenal gland cancer	0.00141	0.00953	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—RRM1—adrenal gland cancer	0.00141	0.00953	CbGpPWpGaD
Dobutamine—ADRB1—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00138	0.00935	CbGpPWpGaD
Dobutamine—COMT—Biological oxidations—POMC—adrenal gland cancer	0.00135	0.00917	CbGpPWpGaD
Dobutamine—ADRB2—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00135	0.00915	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—SDHD—adrenal gland cancer	0.00131	0.0089	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—RRM1—adrenal gland cancer	0.00131	0.0089	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00127	0.0086	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00124	0.00841	CbGpPWpGaD
Dobutamine—COMT—Metabolism—SDHB—adrenal gland cancer	0.00121	0.0082	CbGpPWpGaD
Dobutamine—ADRB1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00119	0.00807	CbGpPWpGaD
Dobutamine—COMT—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00118	0.00802	CbGpPWpGaD
Dobutamine—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00117	0.0079	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00113	0.00766	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00111	0.0075	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—MED12—adrenal gland cancer	0.00105	0.00711	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—MED12—adrenal gland cancer	0.000979	0.00663	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000967	0.00655	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000945	0.00641	CbGpPWpGaD
Dobutamine—CA2—Metabolism—RRM1—adrenal gland cancer	0.00093	0.0063	CbGpPWpGaD
Dobutamine—CA2—Metabolism—SDHD—adrenal gland cancer	0.00093	0.0063	CbGpPWpGaD
Dobutamine—ADRB1—G alpha (s) signalling events—POMC—adrenal gland cancer	0.000929	0.0063	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000912	0.00618	CbGpPWpGaD
Dobutamine—ADRB2—G alpha (s) signalling events—POMC—adrenal gland cancer	0.000909	0.00616	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—BRAF—adrenal gland cancer	0.000907	0.00615	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000892	0.00604	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—TSHR—adrenal gland cancer	0.000861	0.00584	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—TSHR—adrenal gland cancer	0.000843	0.00571	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000828	0.00561	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00081	0.00549	CbGpPWpGaD
Dobutamine—COMT—Metabolism—RRM1—adrenal gland cancer	0.00078	0.00528	CbGpPWpGaD
Dobutamine—COMT—Metabolism—SDHD—adrenal gland cancer	0.00078	0.00528	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PRKACA—adrenal gland cancer	0.000765	0.00518	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PRKACA—adrenal gland cancer	0.000714	0.00484	CbGpPWpGaD
Dobutamine—CA2—Metabolism—MED12—adrenal gland cancer	0.000694	0.0047	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GNAS—adrenal gland cancer	0.00062	0.0042	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—ABCB1—adrenal gland cancer	0.000609	0.00412	CbGpPWpGaD
Dobutamine—COMT—Metabolism—MED12—adrenal gland cancer	0.000581	0.00394	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GNAS—adrenal gland cancer	0.000579	0.00392	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ABCB1—adrenal gland cancer	0.000568	0.00385	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000546	0.0037	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000534	0.00362	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PRKACA—adrenal gland cancer	0.000506	0.00343	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—GNAS—adrenal gland cancer	0.000501	0.0034	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000496	0.00336	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00049	0.00332	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000489	0.00331	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000487	0.0033	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000485	0.00329	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000478	0.00324	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000476	0.00323	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000455	0.00308	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000445	0.00301	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000443	0.003	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000442	0.003	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000433	0.00294	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000432	0.00293	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000428	0.0029	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PRKACA—adrenal gland cancer	0.000424	0.00287	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000418	0.00283	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—POMC—adrenal gland cancer	0.000418	0.00283	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GNAS—adrenal gland cancer	0.00041	0.00278	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ABCB1—adrenal gland cancer	0.000402	0.00273	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—POMC—adrenal gland cancer	0.00039	0.00264	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GNAS—adrenal gland cancer	0.000344	0.00233	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—POMC—adrenal gland cancer	0.000337	0.00229	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ABCB1—adrenal gland cancer	0.000337	0.00228	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PTGS2—adrenal gland cancer	0.000333	0.00226	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—POMC—adrenal gland cancer	0.00033	0.00224	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000317	0.00215	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PTGS2—adrenal gland cancer	0.000311	0.00211	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00031	0.0021	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000296	0.00201	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000293	0.00199	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00029	0.00196	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000287	0.00194	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000283	0.00192	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000277	0.00188	CbGpPWpGaD
Dobutamine—CA2—Metabolism—POMC—adrenal gland cancer	0.000276	0.00187	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000269	0.00182	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000268	0.00182	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000263	0.00178	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000262	0.00178	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TSHR—adrenal gland cancer	0.000261	0.00177	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000257	0.00174	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TSHR—adrenal gland cancer	0.000255	0.00173	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000252	0.0017	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MEN1—adrenal gland cancer	0.000246	0.00166	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MEN1—adrenal gland cancer	0.00024	0.00163	CbGpPWpGaD
Dobutamine—COMT—Metabolism—POMC—adrenal gland cancer	0.000231	0.00157	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTGS2—adrenal gland cancer	0.00022	0.00149	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000191	0.00129	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000187	0.00127	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000187	0.00126	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTGS2—adrenal gland cancer	0.000185	0.00125	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000183	0.00124	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—POMC—adrenal gland cancer	0.000173	0.00117	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—POMC—adrenal gland cancer	0.000169	0.00115	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDC42—adrenal gland cancer	0.000159	0.00108	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDC42—adrenal gland cancer	0.000156	0.00105	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF2—adrenal gland cancer	0.000153	0.00104	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GNAS—adrenal gland cancer	0.000152	0.00103	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF2—adrenal gland cancer	0.00015	0.00102	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GNAS—adrenal gland cancer	0.000149	0.00101	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000148	0.001	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000145	0.000982	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TERT—adrenal gland cancer	0.000128	0.000864	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TERT—adrenal gland cancer	0.000125	0.000845	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BAD—adrenal gland cancer	0.000111	0.000752	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BAD—adrenal gland cancer	0.000109	0.000735	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—POMC—adrenal gland cancer	0.000102	0.000693	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BRAF—adrenal gland cancer	0.000101	0.000684	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—POMC—adrenal gland cancer	0.0001	0.000678	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BRAF—adrenal gland cancer	9.88e-05	0.000669	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—EGFR—adrenal gland cancer	9.79e-05	0.000663	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EGFR—adrenal gland cancer	9.58e-05	0.000649	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CTNNB1—adrenal gland cancer	7.3e-05	0.000495	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CTNNB1—adrenal gland cancer	7.14e-05	0.000484	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EGFR—adrenal gland cancer	5.78e-05	0.000392	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EGFR—adrenal gland cancer	5.66e-05	0.000383	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TP53—adrenal gland cancer	4.86e-05	0.000329	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TP53—adrenal gland cancer	4.75e-05	0.000322	CbGpPWpGaD
